U.S., May 7 -- An application to own the trademark for 'SNIM' has been filed on Dec. 21, 2023.
Owner(s):
Ethris GmbH; Semmelweisstr. 3, 82152 Planegg, GERMANY
Goods and/or Services:
For: Pharmaceuticals for immunization and/or prevention or treatment of diseases and conditions affecting various body systems, namely, respiratory system diseases, in particular lung diseases, airway diseases, or nasal diseases more specifically, lung viral diseases, lung ciliopathies, and lung autoimmune diseases, pathogen infections, namely viral, bacterial, fungal or parasitic infections and pathogen-caused diseases, namely respiratory system diseases, in particular viral induced asthma, congenital diseases, autoimmune diseases, immune system diseases, n...